|
UFM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.10462807976364E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55111512312578E-16 |
| Normal-vs-Stage2 |
8.12410000000652E-05 |
| Normal-vs-Stage3 |
4.958000E-04 |
| Normal-vs-Stage4 |
3.963600E-04 |
| Stage1-vs-Stage2 |
4.902200E-01 |
| Stage1-vs-Stage3 |
1.143860E-02 |
| Stage1-vs-Stage4 |
4.420300E-03 |
| Stage2-vs-Stage3 |
5.115700E-02 |
| Stage2-vs-Stage4 |
3.832100E-02 |
| Stage3-vs-Stage4 |
8.887000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6645573808205E-12 |
| Normal-vs-AfricanAmerican |
1.029500E-02 |
| Normal-vs-Asian |
7.91749999999869E-05 |
| Caucasian-vs-AfricanAmerican |
4.536800E-03 |
| Caucasian-vs-Asian |
5.605400E-01 |
| AfricanAmerican-vs-Asian |
6.290400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.16269993633011E-10 |
| Normal-vs-Female |
1.65534252971611E-13 |
| Male-vs-Female |
1.011820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.498500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.2490009027033E-11 |
| Normal-vs-Age(61-80Yrs) |
3.26909610492976E-11 |
| Normal-vs-Age(81-100Yrs) |
6.680300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.160420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.423970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.542000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.525400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.215800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.898200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.75319999629053E-08 |
| Normal-vs-Grade 2 |
1.62525548574877E-12 |
| Normal-vs-Grade 3 |
2.46460000186133E-08 |
| Normal-vs-Grade 4 |
5.011700E-02 |
| Grade 1-vs-Grade 2 |
5.067000E-01 |
| Grade 1-vs-Grade 3 |
2.594300E-02 |
| Grade 1-vs-Grade 4 |
2.882700E-03 |
| Grade 2-vs-Grade 3 |
1.786060E-04 |
| Grade 2-vs-Grade 4 |
1.32460000001888E-06 |
| Grade 3-vs-Grade 4 |
2.888400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.263510E-03 |
| ccA subtype-vs-ccB subtype |
1.7388979145494E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37659994514649E-09 |
| Normal-vs-N1 |
5.445000E-01 |
| N0-vs-N1 |
1.162600E-01 |
|
|
